Rofecoxib does not adversely affect skin graft survival in a rat model.
Miller
Quintessa
Q
Department of Surgery, Keesler Medical Center, Keesler Air Force Base, Suite 1A132, 301 Fisher Street, MS 30534, USA. miller.quintessa@keesler.af.mil
Losken
Albert
A
Harre
Joseph G
JG
Bird
Maj Erin T
ME
D000208:Acute Disease; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D006085:Graft Survival / Q000187:drug effects*; D007783:Lactones / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009336:Necrosis; D010149:Postoperative Pain / Q000188:drug therapy; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D016037:Single-Blind Method; D016038:Skin Transplantation; D013450:Sulfones; D013927:Thrombosis / Q000139:chemically induced; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib